280. 巨大動静脈奇形(頚部顔面又は四肢病変) Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 29 / 薬物数 : 31 - (DrugBank : 15) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 163

薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
68GA-NEB
   Peking Union Medical College Hospital
      2014   Phase 1   NCT02496013   China
Alpelisib
   Murdoch Childrens Research Institute
      2024   Phase 2   NCT05983159   Australia
Bevacizumab
   University of California, San Francisco
      2016   Phase 1   NCT02314377   United States
Bleomycin
   Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
      2016   -   ChiCTR-IOR-16008047   China
      2014   -   ChiCTR-OOB-15007258   China
Blood sample
   Fondation Ophtalmologique Adolphe de Rothschild
      2022   -   NCT04772963   France
Blood samples
   Assistance Publique Hopitaux De Marseille
      2013   -   NCT01774916   France
Cobimetinib
   University of Arkansas
      2022   Phase 2   NCT05125471   United States
Dexmedetomidine
   Nan Jiang
      2016   -   NCT03076099   China
Dexmedetomidine 1
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China
Dexmedetomidine 2
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China
Dexmedetomidine 3
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China
Doxycycline
   University of California, San Francisco
      2008   Phase 1   NCT00783523   United States
      2004   Phase 1   NCT00243893   United States
Ethanol
   Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
      2018   -   ChiCTR1800017616   China
      2018   -   ChiCTR1800015220   China
   Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University
      2020   -   ChiCTR2000036597   China
      2020   -   ChiCTR2000036576   China
Haemoblock
   Center for Vascular Pathology, Moscow
      2020   Phase 4   NCT04999618   Russian Federation
Heparin sodium
   Beijing Tiantan Hospital
      2016   -   NCT03306836   China
L04aa10
   CHRU TOURS
      2019   Phase 2   EUCTR2019-001530-33-FR   France
Lipiodol® ultra fluid with surgical glues
   Guerbet
      2017   Phase 4   NCT02625389   India
Lovastatin
   Beijing Tiantan Hospital
      2021   Phase 2   NCT04297033   China
Mekinist
   Cliniques universitaires Saint-Luc
      -   Phase 2   EUCTR2019-003573-26-BE   Belgium
Minocycline
   University of California, San Francisco
      2004   Phase 1   NCT00243893   United States
Mirdametinib
   Murdoch Childrens Research Institute
      2024   Phase 2   NCT05983159   Australia
Normal saline
   Nan Jiang
      2016   -   NCT03076099   China
Rapamune
   CHRU TOURS
      2019   Phase 2   EUCTR2019-001530-33-FR   France
Rapamune 0.5 MG coated tablets
   CHU Amiens
      2014   Phase 2   EUCTR2011-000321-69-FR   France
Rapamune 1 MG/ML oral solution
   CHU Amiens
      2014   Phase 2   EUCTR2011-000321-69-FR   France
Sirolimus
   Centre Hospitalier Universitaire, Amiens
      2014   Phase 2   NCT02042326   Belgium;France
   Gifu University
      2017   -   JPRN-UMIN000030522   Japan
Sirolimus 0,1% CRèME
   CHRU TOURS
      2019   Phase 2   EUCTR2018-001359-11-FR   France
Sirolimus 1MG/ML
   CHRU TOURS
      2019   Phase 2   EUCTR2019-001530-33-FR   France
Sufentanil
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China
Thalidomide
   Northport Veterans Affairs Medical Center
      2006   Phase 2   NCT00389935   United States
   Xuanwu Hospital, Capital Medical University
      2019   Phase 0   ChiCTR1900021901   China
Trametinib tablet
   University Health Network, Toronto
      2024   Phase 2   NCT06098872   Canada